Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.060
-0.020 (-1.85%)
Sep 17, 2025, 3:30 PM EDT - Market open
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $25.29 million as of September 17, 2025. Its market cap has increased by 6.71% in one year.
Market Cap
25.29M
Enterprise Value
6.74M
1-Year Change
6.71%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $25.29M, a decrease of -72.72%. That is a compound annual growth rate of -11.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 25.40M | -1.17% |
| Dec 31, 2024 | 25.70M | -48.80% |
| Dec 29, 2023 | 50.20M | -30.76% |
| Dec 30, 2022 | 72.50M | -36.74% |
| Dec 31, 2021 | 114.60M | 31.57% |
| Dec 31, 2020 | 87.10M | 2,388.57% |
| Dec 31, 2019 | 3.50M | 34.62% |
| Dec 31, 2018 | 2.60M | -65.33% |
| Dec 29, 2017 | 7.50M | -49.32% |
| Dec 30, 2016 | 14.80M | -73.14% |
| Dec 31, 2015 | 55.10M | -33.69% |
| Dec 31, 2014 | 83.10M | -10.36% |
| Jul 31, 2014 | 92.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |